as both diagnostic biomarkers and
therapeutic targets for IAs. CircRNAs have demonstrated their influence
BEYLERLI, OZAL,
BEERAKA, NARASIMHA M.,
GAREEV, ILGIZ,
PAVLOV, VALENTIN,
YANG, GUANG,
LIANG, YANCHAO,
ALIEV, GJUMRAKCH (2020) of implementing circulating miRNAs as innovative diagnostic and
therapeutic agents for PA is one of the main
Karasev, S.M.,
Sufianov, A.A.,
Khafizov, R.R.,
Karaseva, I.I.,
Shugushev, Z.K.,
Maximkin, D.A.,
Khafizov, T.N. (2021) common pathology, which remains one of the most diagnostically and
therapeutically complex diseases
YANG, G.,
SUN, J.,
SHI, H.,
ZHAO, S.,
GAREEV, I.,
BEYLERLI, O.,
PAVLOV, V.,
IZMAILOV, A. (2020) RNAs can represent not only potential biomarkers but also become new
therapeutic agents and be used
TUGUZBAEVA, G.,
YUE, E.,
CHEN, X.,
HE, L.,
LI, X.,
JU, J.,
QIN, Y.,
PAVLOV, V.,
LU, Y.,
JIA, W.,
BAI, Y.,
NIU, Y.,
YANG, B (2019) -dissociating
therapeutic agent in vitro. Firstly, we found marked enrichment of αv integrin in collectively invading
Beylerli, Ozal,
Beilerli, Aferin,
Shumadalova, Alina,
Wang, Xiaoxiong,
Yang, Mingchun,
Sun, Hanran,
Teng, Lei (2022) , and cell invasion. Polyphenolic compounds are emerging as promising
agents for combating the progression
this problem it is proposed to use a multi-
agent approach. This approach will take into account clinical
Gareev, Ilgiz,
Beylerli, Ozal,
Tamrazov, Rasim,
Ilyasova, Tatiana,
Shumadalova, Alina,
Du, Weijie,
Yang, Baofeng (2023) therapeutic agents directly to the tumor tissue. Presently, there is a worldwide effort to conduct intricate
as
therapeutic targets and
agents. This review provides current knowledge about the role of mi